Ireland's QUMAS unveils compliance package
compliance product, QUMAS Visa, at the 39th Annual Meeting of the
Drug Information Association in San Antonio, Texas, 15-19 June.
Cork, Ireland-based QUMAS has said it will launch its latest regulatory compliance product, QUMAS Visa, at the 39th Annual Meeting of the Drug Information Association in San Antonio, Texas, 15-19 June.
QUMAS Visa is a web-based viewing client for the company's flagship e-DocCompliance application, which manages documentation in compliance with the US Food and Drug Administration (including 21 CFR Part 11), European Medicines Evaluation Agency and other international regulatory bodies.
The software acts as a gateway to an organisation's secure document repository, delivering on-demand access to regulatory-controlled information, according to QUMAS. The product will be available for purchase beginning in mid-June, with pricing on a sliding scale dependent on the size and scope of implementation.
